View Cart  

Florida CMO Flagged by FDA for Unjustified Process Deviations

Axara Pharmaceuticals has not justified deviations from process control procedures that resulted in drug products gone astray and equipment cleaning confusion, according to an FDA Form 483.

To View This Article:


Subscribe To Drug GMP Report

Buy This Article Now

Add this article to your cart for $135.00